Technical Analysis for INM - InMed Pharmaceuticals Inc.

Grade Last Price % Change Price Change
F 0.36 -1.36% 0.00
INM closed down 1.36 percent on Monday, March 18, 2024, on 40 percent of normal volume. It ran into resistance at its 50 day moving average. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or bounces.
0 Watchers
Watchlist Portfolio

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Strong Down Down Flat

Date Alert Name Type % Chg
50 DMA Resistance Bearish 0.00%
Calm After Storm Range Contraction 0.00%
Stochastic Reached Oversold Weakness 0.00%
Wide Bands Range Expansion 0.00%
Oversold Stochastic Weakness 0.00%
50 DMA Resistance Bearish -1.36%
Non-ADX 1,2,3,4 Bearish Bearish Swing Setup -1.36%
Calm After Storm Range Contraction -1.36%
Wide Bands Range Expansion -1.36%
Oversold Stochastic Weakness -1.36%

   Recent Intraday Alerts

Alert Time
60 Minute Opening Range Breakdown about 11 hours ago
Fell Below 10 DMA about 11 hours ago
10 DMA Support about 12 hours ago
Rose Above 50 DMA about 12 hours ago
1.5x Volume Pace about 12 hours ago

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

InMed Pharmaceuticals Inc. Description

InMed Pharmaceuticals Inc., a clinical stage pharmaceutical company, researches and develops cannabinoid-based therapies. The company's lead product is INM-755, a cannabinol topical cream, which is in a second Phase I clinical trials for the treatment of epidermolysis bullosa. The company is also involved in developing INM-088, which is in preclinical studies for the treatment of glaucoma; and INM-405 for the treatment of orofacial pain. In addition, it engages in the development of cannabinoid-based treatments for various diseases, including dermatology and ocular diseases. Further, it works on IND-enabling pharmacology and preclinical toxicology studies. The company was formerly known as Cannabis Technologies Inc. and changed its name to InMed Pharmaceuticals Inc. in October 2014. InMed Pharmaceuticals Inc. was incorporated in 1981 and is based in Vancouver, Canada.


Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Disease Rare Diseases Cannabis Pharmacology Dermatology Stage Pharmaceutical Glaucoma Toxicology Genodermatoses Cannabinoid Treatment Of Glaucoma Epidermolysis Bullosa Ocular Disease

Is INM a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 2.08
52 Week Low 0.2913
Average Volume 180,955
200-Day Moving Average 0.66
50-Day Moving Average 0.37
20-Day Moving Average 0.38
10-Day Moving Average 0.36
Average True Range 0.04
RSI (14) 45.36
ADX 33.59
+DI 28.98
-DI 9.29
Chandelier Exit (Long, 3 ATRs) 0.34
Chandelier Exit (Short, 3 ATRs) 0.45
Upper Bollinger Bands 0.44
Lower Bollinger Band 0.32
Percent B (%b) 0.28
BandWidth 32.17
MACD Line -0.01
MACD Signal Line 0.00
MACD Histogram -0.0039
Fundamentals Value
Market Cap 2.34 Million
Num Shares 6.6 Million
EPS 0.05
Price-to-Earnings (P/E) Ratio 7.10
Price-to-Sales 0.48
Price-to-Book 0.23
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 0.39
Resistance 3 (R3) 0.39 0.38 0.39
Resistance 2 (R2) 0.38 0.37 0.38 0.38
Resistance 1 (R1) 0.37 0.37 0.36 0.37 0.38
Pivot Point 0.36 0.36 0.35 0.36 0.36
Support 1 (S1) 0.34 0.35 0.34 0.34 0.33
Support 2 (S2) 0.33 0.34 0.33 0.33
Support 3 (S3) 0.32 0.33 0.32
Support 4 (S4) 0.32